Sacral Fracture Outcomes |
||||
Status |
Steering Committee |
Study Materials |
Jump To |
|
Open and Enrolling |
Mo Bhandari |
|||
Jim Goulet |
||||
Cliff Jones |
||||
Study Registration |
Sean Nork | |||
6. Sacral Fractures |
NCT00798733 |
Dave Templeman |
||
7. Ankle Plating |
Paul Tornetta |
|||
Title A Multicenter Prospective Cohort Study of Sacral Fractures Using Patient Based and Objective Outcomes.
There is wide variation in the current
treatment of pelvic ring trauma. This divergence in practice patterns
includes the use of either operative or non-operative care for the same
fractures. Sacral fractures are among the most common pelvic injuries,
comprising 75% of all those seen at most centers. The appropriate treatment
of this fracture is vigorously debated despite the common goal of improving
patient outcomes. While significant displacement is a universal operative
indication in healthy individuals, lesser degrees of displacement are
treated operatively and nonoperatively.
[return to top]
This project will be a
prospective observational cohort study of all unilateral sacral fractures
seen across 20+ trauma centers. Inclusion criteria will be all patients 18
– 80 yo with unilateral sacral fractures. Patients unable to comply with
outcome measures, prisoners, pregnant women, those with APC injuries, Zone 3
sacral fractures, and those unable to comply with followup will be
excluded. As there is substantial variation in the treatment protocols
between centers, the study will be designed as observational, with
comparisons of outcomes for similar injuries being performed apriori after
the study is complete. In particular, there is interest in evaluating the
VAS and outcomes data for “minimally” displaced fractures treated
operatively and nonoperatively. Minimally displaced will be defined as less
than 8mm displacement of the sacrum. Thus, operative and nonoperative cases
will be included. All patients will follow the same postoperative protocol
if possible based on additional injuries. Multiple trauma patients will be
included. Data on
operative cases will be gathered including the method of reduction, the
implants utilized posteriorly and anteriorly.
Baseline information on each awake and alert patient will be obtained during their initial hospitalization. The Majeed pelvic score, the SMFA, MMSE, and a visual analog scale for pain (0-10) will be utilized. The VAS pain will be obtained within the first 24 hours, at 7-10 days, and at 21 ± 7 days in addition to all scheduled follow-ups. The validated outcome scores will be obtained at the initial hospitalization, the 3 month, 6 month, 9 month, 12 month, and if available, the 24 month followup.
|